ferrous sulfate has been researched along with losartan potassium in 55 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.82) | 18.7374 |
| 1990's | 25 (45.45) | 18.2507 |
| 2000's | 18 (32.73) | 29.6817 |
| 2010's | 9 (16.36) | 24.3611 |
| 2020's | 2 (3.64) | 2.80 |
| Authors | Studies |
|---|---|
| Cook, JD; Skikne, BS | 1 |
| Van Wyck, DB | 1 |
| Bourantas, KL; Georgiou, I; Seferiadis, K | 1 |
| Kubanek, B; Noé, G; Rich, I | 1 |
| Altin, M; Demirtürk, L; Hülagü, S; Ozel, M; Yaylaci, M | 1 |
| Dover, GJ; Nienhuis, AW; Noguchi, CT; Rodgers, GP; Schechter, AN; Uyesaka, N | 1 |
| Friedman, EA; Khurana, E; Lundin, AP; Rao, TK; Shrivastava, D; Sinert, R | 1 |
| Hakim, RM; Ismail, N; Parker, RA; Wingard, RL | 1 |
| Berriman, AM; Feig, SA; Freedman, MH; Olivieri, NF; Shore, R; Valentino, L | 1 |
| Dempsey, WH; Lavey, RS | 1 |
| Collins, SL; Timberlake, GA | 1 |
| Abel, R; Fabry, ME; Johnson, R; Mangahas, L; Nagel, RL; Shah, M; Spadacino, E; Stamatoyannopoulos, G; Vichinsky, E | 1 |
| Brugnara, C; Chambers, LA; Goldberg, MA; Kruskall, MS; Malynn, E | 1 |
| Barker, JA; Hartman, KR | 1 |
| Blum, M; Frank, N; Iaina, A; Kaplan, E; Levi, BA; Peer, G; Silverberg, DS; Steinbruch, S | 1 |
| McClelland, B | 1 |
| Adamson, J | 2 |
| Gombotz, H | 1 |
| Bastani, B; Martin, KJ; Tinawi, M | 1 |
| College, J | 1 |
| Blum, S; Dave, M; Henriquez, M; Kotaki, M; Uday, K | 1 |
| Ahluwalia, N; Chonko, A; Savin, V; Skikne, BS | 1 |
| Bali, M; Dilmen, U; Duranay, M; Sahin, M; Vurgun, N; Yakinci, G | 1 |
| Bhandari, S; Brownjohn, A; Turney, J | 1 |
| Antunes, I; Granjo, E; Mesquita-Guimãres, J; Resende, C | 1 |
| Andrea, C; Caramelo, C; Garvía, R; Goicoechea, M; Ochando, A; Ortiz, A | 1 |
| Audo, A; Barberis, L; Carmagnini, E; Crivellari, R; Dottori, V; Lijoi, A; Parodi, E; Passerone, G; Podestà, A | 1 |
| Haas, T; Haluzík, M; Marková, M; Nedvídková, J; Rosická, M; Svobodová, J | 1 |
| Inglis, H; Newstead, CG; Stoves, J | 1 |
| Christopoulou, M; Derartinian, H; Hatzidimitriou, G; Iatrou, L | 1 |
| Campbell, SB; Gissane, R; Hawley, CM; Herzig, KA; Isbel, NM; Johnson, DW | 1 |
| Crivellari, R; Dottori, V; Parodi, E; Passerone, GC; Podestà, A | 1 |
| Croucher, C; Findley, I; Kalu, E; Manyonda, I; Wayne, C | 1 |
| Juul, SE; Strandjord, TP; Woodrum, DE; Zerzan, JC | 1 |
| Kasimatis, G; Kourtzis, N; Pafilas, D | 1 |
| Lo Giudice, S; Pennisi, MG; Reale, S; Venza, M; Vitale, F | 1 |
| Goshorn, J; Youell, TD | 1 |
| Bailey, DM; Lundby, C; Robach, P; Thomsen, JJ | 1 |
| Chen, YC; Fang, JT; Hsu, PY; Huang, JY; Jenq, CC; Tian, YC; Wu, HH; Yang, CW | 1 |
| Johnson, DW | 1 |
| Skoner, JM; Wax, MK | 1 |
| Krasnoperova, OV; Nikitin, EN; Nikitin, IuE | 1 |
| Barraclough, KA; Brown, F; Campbell, SB; Hawley, CM; Isbel, NM; Johnson, DW; Leary, D; Mudge, DW; Noble, E; Sturtevant, JM; van Eps, CL | 1 |
| Besarab, A; Chalhoub, E; Faber, MD; Frinak, S; Peterson, E; Yee, J; Zasuwa, G | 1 |
| Bicanic, G; Buljan, M; Delimar, D; Golubic-Cepulic, B; Nemet, D; Tripkovic, B | 1 |
| Auerbach, MA; Dahl, NV; Henry, DH | 1 |
| Barraclough, KA; Brown, F; Campbell, SB; Hawley, CM; Isbel, NM; Johnson, DW; Leary, D; Mudge, DW; Noble, E; van Eps, CL | 1 |
| Lynn, S; McDaniel, J | 1 |
| Bao, S; Dong, C; Gao, X; Han, T; Xu, C | 1 |
| Angeles-Torres, AC; Castro-Cortina, N; Castro-Melendez, SE; Escobar-Valencia, A; Quiroga-Garza, A; Sanchez-Gonzalez, LR | 1 |
| Bagna, R; Bertino, E; Boetti, T; Cester, EA; Coscia, A; Mazzone, R; Saracco, P; Spada, E | 1 |
| Eichner, D; Garvican-Lewis, LA; Gore, CJ; Govus, AD; Hughes, D; Jung, G; Lovell, G; Nemeth, E; Peeling, P; Vuong, VL | 1 |
| Liljeberg, K; Lim, PK; Stewart, CN; Sylvanus, TS; Wood, RJ | 1 |
| Brearley, AM; Georgieff, MK; Northrop, E; Olson, RM; Rao, R; Siddappa, AM; Spector, M; Zamora, T | 1 |
3 review(s) available for ferrous sulfate and losartan potassium
| Article | Year |
|---|---|
[Erythropoietin].
Topics: Anemia; Blood Transfusion; Combined Modality Therapy; Dose-Response Relationship, Drug; Erythropoiesis; Erythropoietin; Ferrous Compounds; Hemoglobinometry; Humans; Palliative Care; Recombinant Proteins | 1994 |
Potential of epoetin alfa in patients in autologous blood donation programs for orthopedic surgery.
Topics: Anemia; Blood Transfusion, Autologous; Epoetin Alfa; Erythropoiesis; Erythropoietin; Ferrous Compounds; Hematocrit; Hemoglobins; Humans; Injections, Intravenous; Injections, Subcutaneous; Orthopedics; Premedication; Recombinant Proteins | 1996 |
Intravenous versus oral iron supplementation in peritoneal dialysis patients.
Topics: Administration, Oral; Clinical Trials as Topic; Darbepoetin alfa; Erythropoietin; Ferric Compounds; Ferritins; Ferrous Compounds; Hemoglobins; Humans; Infusions, Intravenous; Iron; Peritoneal Dialysis; Recombinant Proteins; Transferrin | 2007 |
17 trial(s) available for ferrous sulfate and losartan potassium
| Article | Year |
|---|---|
Efficacy of oral iron therapy in patients receiving recombinant human erythropoietin.
Topics: Administration, Oral; Anemia; Anemia, Iron-Deficiency; Delayed-Action Preparations; Erythropoietin; Female; Ferrous Compounds; Hematocrit; Humans; Iron; Kidney Failure, Chronic; Male; Middle Aged; Patient Compliance; Polysaccharides; Prospective Studies; Recombinant Proteins; Renal Dialysis | 1995 |
Erythropoietin increases hemoglobin in cancer patients during radiation therapy.
Topics: Erythropoietin; Female; Ferrous Compounds; Hemoglobins; Humans; Leukocyte Count; Male; Middle Aged; Neoplasms; Platelet Count; Radiotherapy; Recombinant Proteins | 1993 |
F reticulocyte response in sickle cell anemia treated with recombinant human erythropoietin: a double-blind study.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Double-Blind Method; Erythrocyte Count; Erythropoietin; Female; Ferritins; Ferrous Compounds; Humans; Male; Middle Aged; Recombinant Proteins; Reticulocytes | 1993 |
Potential of epoetin alfa in patients in autologous blood donation programs for orthopedic surgery.
Topics: Anemia; Blood Transfusion, Autologous; Epoetin Alfa; Erythropoiesis; Erythropoietin; Ferrous Compounds; Hematocrit; Hemoglobins; Humans; Injections, Intravenous; Injections, Subcutaneous; Orthopedics; Premedication; Recombinant Proteins | 1996 |
Epoetin alfa as an adjunct to autologous blood donation in patients with a low hematocrit scheduled for elective orthopedic surgery.
Topics: Anemia; Blood Transfusion; Blood Transfusion, Autologous; Double-Blind Method; Elective Surgical Procedures; Epoetin Alfa; Erythropoiesis; Erythropoietin; Female; Ferrous Compounds; Hematocrit; Humans; Male; Orthopedics; Premedication; Recombinant Proteins; Treatment Outcome | 1996 |
Perisurgical use of epoetin alfa in orthopedic surgery patients.
Topics: Anemia; Blood Transfusion; Dose-Response Relationship, Drug; Double-Blind Method; Elective Surgical Procedures; Epoetin Alfa; Erythropoiesis; Erythropoietin; Ferrous Compounds; Humans; Injections, Subcutaneous; Orthopedics; Premedication; Recombinant Proteins; Transferrin; Treatment Outcome | 1996 |
Oral iron absorption test in patients on CAPD: comparison of ferrous sulfate and a polysaccharide ferric complex.
Topics: Administration, Oral; Adult; Erythropoietin; Female; Ferrous Compounds; Humans; Intestinal Absorption; Iron; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Polysaccharides; Prospective Studies; Recombinant Proteins; Reference Values; Time Factors | 1996 |
Maintenance therapy with intravenous iron in hemodialysis patients receiving erythropoietin.
Topics: Administration, Oral; Anemia; Anemia, Iron-Deficiency; Delayed-Action Preparations; Drug Administration Schedule; Erythropoietin; Female; Ferritins; Ferrous Compounds; Humans; Injections, Intravenous; Iron; Kidney Failure, Chronic; Male; Middle Aged; Recombinant Proteins; Renal Dialysis | 1997 |
Effective utilization of erythropoietin with intravenous iron therapy.
Topics: Adult; Aged; Aged, 80 and over; Erythropoietin; Female; Ferritins; Ferrous Compounds; Hematinics; Hemoglobins; Humans; Injections, Intravenous; Iron-Dextran Complex; Iron, Dietary; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Renal Dialysis | 1998 |
Elective coronary and valve surgery without blood transfusion in patients treated with recombinant human erythropoietin (epoetin-alpha).
Topics: Blood Loss, Surgical; Coronary Disease; Elective Surgical Procedures; Epoetin Alfa; Erythropoietin; Female; Ferrous Compounds; Heart Valve Diseases; Hematinics; Humans; Male; Middle Aged; Recombinant Proteins | 2000 |
A randomized study of oral vs intravenous iron supplementation in patients with progressive renal insufficiency treated with erythropoietin.
Topics: Administration, Oral; Aged; Disease Progression; Dose-Response Relationship, Drug; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Ferrous Compounds; Gastrointestinal Diseases; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Male; Middle Aged; Recombinant Proteins; Renal Insufficiency | 2001 |
Autologous blood transfusion in oral and maxillofacial surgery patients with the use of erythropoietin.
Topics: Administration, Oral; Adolescent; Adult; Analysis of Variance; Blood Transfusion; Blood Transfusion, Autologous; Elective Surgical Procedures; Erythrocyte Count; Erythropoietin; Facial Bones; Female; Ferrous Compounds; Follow-Up Studies; Head and Neck Neoplasms; Hematocrit; Hemoglobins; Humans; Injections, Intravenous; Male; Middle Aged; Orthognathic Surgical Procedures; Osteotomy; Premedication; Reactive Oxygen Species; Recombinant Proteins; Statistics as Topic | 2001 |
Epoetin alpha in elective coronary and valve surgery in Jehovah's Witnesses patients. Experience in 45 patients.
Topics: Administration, Oral; Aged; Anemia, Hypochromic; Blood Transfusion; Christianity; Coronary Artery Bypass; Elective Surgical Procedures; Epoetin Alfa; Erythropoietin; Female; Ferrous Compounds; Heart Valve Prosthesis Implantation; Heart Valves; Hematinics; Hematocrit; Hemoglobins; Humans; Male; Middle Aged; Recombinant Proteins; Religion and Medicine; Treatment Outcome; Vascular Surgical Procedures | 2002 |
Erythropoietin depletes iron stores: antioxidant neuroprotection for ischemic stroke?
Topics: Adult; Antioxidants; Brain Chemistry; Brain Ischemia; Catalysis; Chelating Agents; Erythropoietin; Ferritins; Ferrous Compounds; Hematocrit; Hemoglobins; Humans; Iron; Male; Neuroprotective Agents; Oxidation-Reduction; Oxidative Stress; Recombinant Proteins; Transferrin | 2006 |
Rationale and design of the oral HEMe iron polypeptide Against Treatment with Oral Controlled Release Iron Tablets trial for the correction of anaemia in peritoneal dialysis patients (HEMATOCRIT trial).
Topics: Administration, Oral; Adult; Anemia; Australia; Chronic Disease; Darbepoetin alfa; Delayed-Action Preparations; Erythropoietin; Ferritins; Ferrous Compounds; Hematinics; Hemeproteins; Hemoglobins; Humans; Iron; Kidney Diseases; Peritoneal Dialysis; Treatment Outcome | 2009 |
A randomized controlled trial of oral heme iron polypeptide versus oral iron supplementation for the treatment of anaemia in peritoneal dialysis patients: HEMATOCRIT trial.
Topics: Administration, Oral; Adult; Aged; Anemia, Iron-Deficiency; Darbepoetin alfa; Dietary Supplements; Erythropoietin; Female; Ferritins; Ferrous Compounds; Hemoglobins; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peptide Fragments; Peritoneal Dialysis; Treatment Outcome | 2012 |
Efficacy and safety of adjuvant recombinant human erythropoietin and ferrous sulfate as treatment for iron deficiency anemia during the third trimester of pregnancy.
Topics: Adult; Anemia, Iron-Deficiency; Drug Therapy, Combination; Erythropoietin; Female; Ferrous Compounds; Humans; Pregnancy; Pregnancy Trimester, Third; Prospective Studies; Recombinant Proteins; Treatment Outcome | 2016 |
36 other study(ies) available for ferrous sulfate and losartan potassium
| Article | Year |
|---|---|
Effect of enhanced erythropoiesis on iron absorption.
Topics: Adult; Erythropoiesis; Erythropoietin; Female; Ferritins; Ferrous Compounds; Food; Heme; Humans; Intestinal Absorption; Iron; Iron Radioisotopes; Male; Recombinant Proteins; Transferrin | 1992 |
Iron management during recombinant human erythropoietin therapy.
Topics: Adult; Anemia; Anemia, Hypochromic; Delayed-Action Preparations; Erythropoietin; Ferrous Compounds; Hematocrit; Humans; Iron-Dextran Complex; Kidney Failure, Chronic; Male; Recombinant Proteins | 1989 |
Fetal globin stimulation during a short-term trial of erythropoietin in HbS/beta-thalassemia patients.
Topics: Adolescent; Adult; Anemia, Sickle Cell; beta-Thalassemia; Child; Drug Evaluation; Drug Therapy, Combination; Erythrocyte Indices; Erythropoietin; Female; Ferrous Compounds; Fetal Hemoglobin; Globins; Humans; Male; Middle Aged; Recombinant Proteins; Stimulation, Chemical; Time Factors | 1994 |
Serum erythropoietin levels in patients with severe anemia secondary to inflammatory bowel disease and the use of recombinant human erythropoietin in patients with anemia refractory to treatment.
Topics: Administration, Oral; Anemia; Anemia, Iron-Deficiency; Colitis, Ulcerative; Crohn Disease; Erythropoietin; Ferrous Compounds; Humans; Inflammatory Bowel Diseases; Injections, Subcutaneous; Recombinant Proteins | 1995 |
Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease.
Topics: Adult; Anemia, Sickle Cell; beta-Thalassemia; Drug Synergism; Drug Therapy, Combination; Erythrocyte Count; Erythrocyte Indices; Erythropoietin; Ferrous Compounds; Fetal Hemoglobin; Humans; Hydroxyurea; Male; Recombinant Proteins; Reticulocytes | 1993 |
The efficacy of erythropoietin in human immunodeficiency virus-infected end-stage renal disease patients treated by maintenance hemodialysis.
Topics: Adult; AIDS-Associated Nephropathy; Anemia; Case-Control Studies; Diabetic Nephropathies; Erythropoietin; Female; Ferrous Compounds; Hematocrit; Humans; Kidney Failure, Chronic; Male; Middle Aged; Recombinant Proteins; Renal Dialysis; Zidovudine | 1995 |
Failure of recombinant human interleukin-3 therapy to induce erythropoiesis in patients with refractory Diamond-Blackfan anemia.
Topics: Adolescent; Bone Marrow; Child; Child, Preschool; Erythrocyte Count; Erythropoiesis; Erythropoietin; Fanconi Anemia; Female; Ferrous Compounds; Humans; Interleukin-3; Male; Prednisone; Recombinant Proteins; Reticulocytes | 1994 |
Severe anemia in the Jehovah's Witness: case report and discussion.
Topics: Anemia; Blood Transfusion; Christianity; Clinical Protocols; Critical Care; Delayed-Action Preparations; Enteral Nutrition; Erythropoietin; Ferrous Compounds; Hemoglobins; Humans; Male; Middle Aged; Multiple Trauma; Oxygen Consumption; Treatment Refusal; Vitamin B 12 | 1993 |
Red blood cell regeneration induced by subcutaneous recombinant erythropoietin: iron-deficient erythropoiesis in iron-replete subjects.
Topics: Blood Donors; Erythrocyte Count; Erythrocyte Indices; Erythropoiesis; Erythropoietin; Ferritins; Ferrous Compounds; Folic Acid; Hematocrit; Hemochromatosis; Hemoglobins; Humans; Iron; Iron Deficiencies; Male; Recombinant Proteins; Reticulocytes; Transferrin; Vitamin B 12 | 1993 |
Microcytic anemia with iron malabsorption: an inherited disorder of iron metabolism.
Topics: Administration, Oral; Anemia, Iron-Deficiency; Animals; Biological Transport; Bone Marrow; Cell Compartmentation; Cell Size; Child; Child, Preschool; Colony-Forming Units Assay; Craniosynostoses; Drug Resistance; Erythrocytes, Abnormal; Erythroid Precursor Cells; Erythropoietin; Female; Ferrous Compounds; Humans; Infusions, Intravenous; Intestinal Absorption; Intracellular Fluid; Iron; Iron-Dextran Complex; Malabsorption Syndromes; Male; Mice; Mice, Mutant Strains | 1996 |
Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysis.
Topics: Administration, Oral; Adult; Aged; Anemia; Anemia, Iron-Deficiency; Delayed-Action Preparations; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Follow-Up Studies; Glucaric Acid; Humans; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Time Factors | 1996 |
Subcutaneous epoetin alfa as an adjunct to autologous blood donation before elective coronary artery bypass graft surgery.
Topics: Anemia; Blood Transfusion, Autologous; Coronary Artery Bypass; Elective Surgical Procedures; Epoetin Alfa; Erythropoiesis; Erythropoietin; Ferrous Compounds; Hemodilution; Hemoglobins; Humans; Injections, Subcutaneous; Male; Premedication; Recombinant Proteins; Treatment Outcome | 1996 |
Epoetin alfa--focus on nutritional therapy. Case study of the anemic patient.
Topics: Aged; Anemia, Iron-Deficiency; Erythropoiesis; Erythropoietin; Female; Ferrous Compounds; Humans; Kidney Failure, Chronic; Nutritional Support; Patient Compliance | 1996 |
Markers of masked iron deficiency and effectiveness of EPO therapy in chronic renal failure.
Topics: Adult; Aged; Anemia; Anemia, Iron-Deficiency; Erythropoiesis; Erythropoietin; Female; Ferritins; Ferrous Compounds; Hemoglobins; Humans; Iron; Kidney Failure, Chronic; Male; Middle Aged; Receptors, Transferrin; Recombinant Proteins; Renal Dialysis; Reticulocyte Count; Sensitivity and Specificity; Time Factors | 1997 |
Parvovirus B19 infection and unresponsiveness to erythropoietin therapy in haemodialysis patients.
Topics: Adolescent; Anemia, Aplastic; Delayed-Action Preparations; Erythropoietin; Ferrous Compounds; Glomerulonephritis; Humans; Kidney Failure, Chronic; Male; Parvoviridae Infections; Parvovirus B19, Human; Renal Dialysis; Uremia | 1998 |
Recombinant human erythropoietin alpha in the correction of anaemia in epidermolysis bullosa.
Topics: Adult; Anemia; Blood Transfusion; Chronic Disease; Delayed-Action Preparations; Epidermolysis Bullosa Dystrophica; Erythropoietin; Female; Ferrous Compounds; Folic Acid; Hematinics; Humans; Recombinant Proteins | 1999 |
Antiplatelet therapy alters iron requirements in hemodialysis patients.
Topics: Administration, Oral; Arteriovenous Shunt, Surgical; Blood Vessel Prosthesis Implantation; Erythropoietin; Female; Ferric Compounds; Ferrous Compounds; Humans; Infusions, Parenteral; Iron Deficiencies; Kidney Failure, Chronic; Male; Middle Aged; Nutritional Requirements; Platelet Aggregation Inhibitors; Prospective Studies; Renal Dialysis | 2000 |
Serum leptin levels in patients with sideropenic and pernicious anemia: the influence of anemia treatment.
Topics: Adult; Aged; Anemia, Pernicious; Anemia, Sideroblastic; Body Mass Index; Erythrocyte Count; Erythropoietin; Female; Ferrous Compounds; Hemoglobins; Humans; Leptin; Male; Middle Aged; Vitamin B 12 | 2000 |
Oral versus intravenous iron supplementation in peritoneal dialysis patients.
Topics: Administration, Oral; Erythropoietin; Ferric Compounds; Ferritins; Ferrous Compounds; Hemoglobins; Humans; Infusions, Intravenous; Iron; Peritoneal Dialysis; Recombinant Proteins; Transferrin | 2001 |
Triplet pregnancy in a Jehovah's witness: recombinant human erythropoietin and iron supplementation for minimising the risks of excessive blood loss.
Topics: Adult; Anticoagulants; Bandages; Blood Loss, Surgical; Cesarean Section; Christianity; Dalteparin; Erythropoietin; Extracorporeal Circulation; Female; Ferrous Compounds; Humans; Pregnancy; Pregnancy Outcome; Pregnancy, Multiple; Recombinant Proteins; Triplets | 2002 |
Zinc protoporphyrin/heme as an indicator of iron status in NICU patients.
Topics: Biomarkers; Blood Cell Count; Erythrocyte Transfusion; Erythropoietin; Ferrous Compounds; Gestational Age; Heme; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Iron Deficiencies; Protoporphyrins; Recombinant Proteins; Reference Values; Risk Factors | 2003 |
Blood saving protocol in elective total knee arthroplasty.
Topics: Aged; Aged, 80 and over; Arthroplasty, Replacement, Knee; Blood Transfusion; Blood Transfusion, Autologous; Clinical Protocols; Erythropoietin; Female; Ferrous Compounds; Folic Acid; Hematinics; Hemostasis, Surgical; Hemostatic Techniques; Humans; Male; Middle Aged; Recombinant Proteins; Retrospective Studies | 2004 |
Case report of leishmaniasis in four cats.
Topics: Allopurinol; Animals; Cat Diseases; Cats; Erythropoietin; Euthanasia, Animal; Female; Ferrous Compounds; Interferon alpha-2; Interferon-alpha; Leishmaniasis; Male; Recombinant Proteins | 2004 |
Darbepoetin alfa treatment for post-renal transplantation anemia during pregnancy.
Topics: Adult; Anemia; Cesarean Section; Contraindications; Cyclosporine; Darbepoetin alfa; Erythropoietin; Female; Ferrous Compounds; Humans; Hydronephrosis; Immunosuppressive Agents; Kidney Transplantation; Nephrostomy, Percutaneous; Postoperative Complications; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy, High-Risk; Puerperal Disorders; Seizures; Sirolimus; Stents; Treatment Refusal | 2005 |
Effectiveness of oral and intravenous iron therapy in haemodialysis patients.
Topics: Administration, Oral; Anemia, Iron-Deficiency; C-Reactive Protein; Chlorides; Erythropoietin; Female; Ferric Compounds; Ferritins; Ferrous Compounds; Hematinics; Hematocrit; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Treatment Outcome | 2008 |
Microvascular free-tissue transfer for head and neck reconstruction in Jehovah's Witness patients.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Carotid Artery, External; Embolization, Therapeutic; Erythropoietin; Female; Ferrous Compounds; Head and Neck Neoplasms; Hematocrit; Humans; Jehovah's Witnesses; Male; Microsurgery; Middle Aged; Perioperative Care; Preoperative Care; Retrospective Studies; Surgical Flaps; Treatment Outcome | 2008 |
[Experience in the treatment of iron deficiency anemia with ferro-folgamma].
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Dose-Response Relationship, Drug; Erythropoietin; Female; Ferrous Compounds; Follow-Up Studies; Hemoglobins; Humans; Iron; Male; Middle Aged; Treatment Outcome; Young Adult | 2009 |
De novo once-monthly darbepoetin alpha treatment for the anemia of chronic kidney disease using a computerized algorithmic approach.
Topics: Algorithms; Anemia; Chronic Disease; Darbepoetin alfa; Drug Administration Schedule; Drug Therapy, Computer-Assisted; Erythropoietin; Female; Ferritins; Ferrous Compounds; Hematinics; Hemoglobins; Humans; Kidney Diseases; Male; Transferrin | 2011 |
Two different dosing regimens of human recombinant erythropoietin beta during preoperative autologous blood donation in patients having hip arthroplasty.
Topics: Administration, Oral; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Blood Transfusion, Autologous; Drug Administration Schedule; Drug Therapy, Combination; Erythropoietin; Female; Ferrous Compounds; Hemoglobins; Humans; Injections, Intravenous; Male; Middle Aged; Osteoarthritis, Hip; Preoperative Care; Recombinant Proteins | 2012 |
Thrombocytosis and venous thromboembolism in cancer patients with chemotherapy induced anemia may be related to ESA induced iron restricted erythropoiesis and reversed by administration of IV iron.
Topics: Aged; Anemia; Anemia, Iron-Deficiency; Antineoplastic Agents; Double-Blind Method; Epoetin Alfa; Erythropoiesis; Erythropoietin; Female; Ferric Compounds; Ferrous Compounds; Hematinics; Hemoglobins; Humans; Iron; Male; Meta-Analysis as Topic; Middle Aged; Multicenter Studies as Topic; Neoplasms; Randomized Controlled Trials as Topic; Recombinant Proteins; Retrospective Studies; Thrombocytosis; Thrombophilia; Venous Thromboembolism | 2012 |
Managing severe anemia when the patient is a Jehovah's Witness.
Topics: Adult; Anemia, Iron-Deficiency; Epoetin Alfa; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Fluid Therapy; Glucaric Acid; Hematinics; Humans; Jehovah's Witnesses; Male; Oxygen Inhalation Therapy; Recombinant Proteins; Severity of Illness Index; Vitamin B 12; Vitamin B Complex | 2013 |
Effect of iron supplementation on the expression of hypoxia-inducible factor and antioxidant status in rats exposed to high-altitude hypoxia environment.
Topics: Altitude; Animals; Antioxidants; Erythropoietin; Ferrous Compounds; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Liver; Male; Malondialdehyde; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transferrin | 2014 |
Efficacy of Supplementation with Iron Sulfate Compared to Iron Bisglycinate Chelate in Preterm Infants.
Topics: Anemia, Iron-Deficiency; Drug Administration Schedule; Drug Therapy, Combination; Erythropoietin; Female; Ferrous Compounds; Hematinics; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Retrospective Studies; Treatment Outcome | 2018 |
Intravenous Iron Does Not Augment the Hemoglobin Mass Response to Simulated Hypoxia.
Topics: Adaptation, Physiological; Administration, Intravenous; Administration, Oral; Adult; Altitude; Dietary Supplements; Erythropoietin; Female; Ferric Compounds; Ferrous Compounds; Hemoglobins; Humans; Hypoxia; Male; Maltose; Physical Conditioning, Human; Physical Endurance; Young Adult | 2018 |
Transfusion-Free Cranial Vault Remodeling: A Novel, Multifaceted Approach.
Topics: Blood Loss, Surgical; Craniosynostoses; Dissection; Epinephrine; Erythropoietin; Female; Ferrous Compounds; Hemodilution; Humans; Infant; Infant, Newborn; Male; Osteotomy; Plastic Surgery Procedures; Vasoconstrictor Agents | 2020 |
High Prevalence of Iron Deficiency Despite Standardized High-Dose Iron Supplementation During Recombinant Erythropoietin Therapy in Extremely Low Gestational Age Newborns.
Topics: Anemia, Iron-Deficiency; Drug Therapy, Combination; Erythropoietin; Female; Ferrous Compounds; Hematinics; Humans; Infant, Extremely Premature; Infant, Newborn; Iron-Dextran Complex; Male; Prevalence; Recombinant Proteins; Retrospective Studies | 2020 |